Best for
Mobile
How to buy e-therapeutics shares
Own e-therapeutics shares in just a few minutes.
e-therapeutics plc is a biotechnology business based in the UK. e-therapeutics shares (ETX.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. e-therapeutics employs 16 staff and has a trailing 12-month revenue of around £305,000.
How to buy shares in e-therapeutics
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ETX in this case.
- Research e-therapeutics shares. The platform should provide the latest information available.
- Buy your e-therapeutics shares. It's that simple.
e-therapeutics share price
Use our graph to track the performance of ETX stocks over time.e-therapeutics shares at a glance
Information last updated 2021-01-23.
| Latest market close | N/Ap |
|---|---|
| 52-week range | 3p - 23p |
| 50-day moving average | 17.5603p |
| 200-day moving average | 14.6504p |
| Wall St. target price | 10p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -1.2p |
Invest in e-therapeutics shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy e-therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
e-therapeutics financials
| Revenue TTM | £305,000 |
|---|---|
| Gross profit TTM | £456,000 |
| Return on assets TTM | -23.16% |
| Return on equity TTM | -32.23% |
| Profit margin | 0% |
| Book value | 0.037p |
| Market capitalisation | £82.9 million |
TTM: trailing 12 months
e-therapeutics share dividends
We're not expecting e-therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
e-therapeutics share price volatility
Over the last 12 months, e-therapeutics's shares have ranged in value from as little as 3p up to 23p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while e-therapeutics's is 0.2395. This would suggest that e-therapeutics's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
e-therapeutics overview
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology. The company has collaborations with C4X Holdings PLC, Intellegens, Biorelate, Novo Nordisk, and Galapagos NV. e-Therapeutics plc was founded in 2001 and is based in Long Hanborough, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy e-therapeutics shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy e-therapeutics shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert